Open AccessA Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan
Author(s) -
Naohiko Fujii,
Takayuki Hamano,
Jesse Y. Hsu,
Enyu Imai,
Tadao Akizawa,
Kosaku Nitta,
Tsuyoshi Watanabe,
Satoshi Iimuro,
Yasuo Ohashi,
Seiichi Matsuo,
Hírofumi Makino,
Akira Hishida,
Arnold B. Alper,
Edward Horwitz,
Chiyuan Hsu,
Anna Porter,
Myles Wolf,
Wei Yang,
Lisa Nessel,
Harold I. Feldman
Publication year - 2022
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000521386
Subject(s) - medicine , kidney disease , renal function , hyperphosphatemia , fibroblast growth factor 23 , endocrinology , parathyroid hormone , cohort , vitamin d and neurology , phosphate , gastroenterology , calcium , chemistry , biochemistry
Recent studies have suggested a higher incidence of cardiovascular disease (CVD) among patients with chronic kidney disease (CKD) in the USA than in Japan. Hyperphosphatemia, a possible risk for CVD, may explain this difference; however, international differences in phosphate parameters in CKD have not been well elaborated.